secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2026-10-08T23:13:53+00:00
Accession:  0001801170-26-000250
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Clover Health PPO MA plans win 5 Stars for 2027; HMO gets 4.5 Stars, lifting payment year 2028
--------------------------------------------------------------------------------

- CMS awarded Clover's PPO Medicare Advantage plans 5 Stars and its HMO MA plan 4.5 Stars for 2027, which affects payment year 2028.
- Rating reflects May 27, 2026 ruling in Clover Insurance Co. v. HHS (S.D. Ga. No. 25-142), on appeal; with the 20 disputed measures included, PPO plans would have scored 4.5 Stars.
- MA membership grew ~48% year-over-year through H1 2026 to more than 157,000 members, with ~98% enrolled in wide-network PPO plans; 5 Stars permits year-round enrollment.
- HEDIS score 4.82 of 5 Stars for a third straight year, ranking #1 among non-SNP PPO plans with over 2,000 members, unchanged under either CMS methodology.
- CEO Andrew Toy Cites 'market leading plans'; MA CEO Jamie Reynoso says the higher rating lets Clover 'reinvest in even more competitive benefits' without compromising financial strength.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000250/0001801170-26-000250-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117026000250/clov-20261008.htm
  HTML page:      https://secwatch.observer/filing/0001801170-26-000250

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer